×

Allergan, Valeant perfect match: CEO

10:48 AM ET Tue, 22 April 2014

CNBC's David Faber and Jeffrey Ubben, ValueAct Capital Partners CEO, discuss Valeant Pharmaceuticals bid for Allergan and why Valeant needed investor Bill Ackman involved in the deal.